Physical Therapists in Ewa Beach, HI Accepting Medicare

9 Physical Therapists found. Showing 1 - 9

Makakilo Physical Therapy And Wellness Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 91-1019 Waikai St, Ewa Beach, HI 96706 Phone: 808-782-5379    Fax: 808-744-6932

Garrett Wakato Okubo, M.S. P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 91-1171 Makaaloa St, Ewa Beach, HI 96706 Phone: 808-258-2125    Fax: 808-488-9854

Optimal Wound Solutions Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 91-1246 Kaikohola St, Ewa Beach, HI 96706 Phone: 808-772-0291

Mr. Grant H Takiguchi, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 91-2139 Fort Weaver Rd, Ste 210, Ewa Beach, HI 96706 Phone: 808-689-9994    Fax: 808-689-9995

Joanne K. Zazzera, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Oceanpointe Outpatient Physical Therapy, 91-6390 Kapolei Pkwy, Ewa Beach, HI 96706 Phone: 808-691-4211    Fax: 808-691-5388

Pt Hawaii, Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 91-2139 Fort Weaver Rd, 202, Ewa Beach, HI 96706 Phone: 808-677-5110    Fax: 808-671-2931

Dana L Hester, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 91-2139 Fort Weaver Rd, Suite 210, Ewa Beach, HI 96706 Phone: 808-689-9994    Fax: 808-689-9995

Gina Bacal, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 91-1019 Hoomaalili St, Ewa Beach, HI 96706 Phone: 808-681-9090

Mrs. Kristen R N Vail, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 91-2139 Fort Weaver Rd, Ste 210, Ewa Beach, HI 96706 Phone: 808-674-9262

News Archive

Genzyme meets FDA consent decree by ending fill/finish activities in Allston plant

Genzyme Corporation announced today that the company has ended fill/finish operations within its Allston plant for products sold in the United States, as required by the FDA consent decree.

Osiris Therapeutics' Prochymal granted FDA Orphan Drug Designation

Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.

Databases of proteins' 3-D shapes help identify more than 850 DNA mutations linked to cancer

Examining databases of proteins' 3-D shapes, scientists at Washington University School of Medicine in St. Louis have identified more than 850 DNA mutations that appear to be linked to cancer.

Fullerene compounds can effectively kill non-small-cell lung carcinoma cells

The team of scientists from Skoltech Center for Energy Science and Technology, the Institute for Problems of Chemical Physics of Russian Academy of Sciences and National Taiwan University have discovered that fullerene compounds can effectively kill non-small-cell lung carcinoma cells and found out the mechanisms behind their anti-tumor activity.

Clinical trials of new drugs to treat most aggressive form of prostate cancer

Clinical trials of new drugs to treat the most aggressive form of prostate cancer are expected to be underway in Brisbane within three years, thanks to Movember Revolutionary Team Award grant that is fast-tracking global research into the disease.

Read more Medical News

› Verified 1 days ago